Regulatory PathRegulatory requirements compared

Active substance

Adapalene

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
ADOLIN 0.1% W-W CREAM0.1 %Cream · Topical1 BottleSAR 17.15Generic · PrescriptionMiddle East Pharmaceutical Industries Co Ltd Avalon PharmaValid
ADOLIN 0.1% W-W GEL0.1 %Gel · Topical1 BottleSAR 17.15Generic · PrescriptionMiddle East Pharmaceutical Industries Co Ltd Avalon PharmaValid
DIFFERIN 0.1% CREAM0.1 %Cream · Topical1 BottleSAR 18.75NCE · PrescriptionGALDERMAValid
DIFFERIN 0.1% GEL0.1 %Gel · Topical1 BottleSAR 18.75NCE · PrescriptionGALDERMAValid
SURECURE 0.1% TOPICAL GEL0.1 %Gel · Topical1 BottleSAR 18.05Generic · PrescriptionJamjoom Pharmaceuticals Factory CompanyValid
WATENE 0.1% CREAM0.1 %Cream · Topical1 BottleSAR 21.95Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
WATENE 0.1% GEL0.1 %Gel · Topical1 BottleSAR 21.95Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
DIFFERIN0.1%gel · topicalGALDERMA LABS LPOver-the-counter31 May 1996
DIFFERIN0.1%cream · topicalGALDERMA LABS LPPrescription26 May 2000
DIFFERIN0.3%gel · topicalGALDERMA LABS LPPrescription19 Jun 2007
ADAPALENE0.1%gel · topicalP AND LOver-the-counter2 Jun 2010
ADAPALENE0.1%cream · topicalFOUGERA PHARMSPrescription30 Jun 2010
ADAPALENE0.1%gel · topicalGLENMARK PHARMSOver-the-counter1 Jul 2010
ADAPALENE0.3%gel · topicalENCUBE ETHICALSPrescription14 Jun 2012
ADAPALENE0.3%gel · topicalACTAVIS MID ATLANTICPrescription27 Oct 2014
ADAPALENE0.1%solution · topicalWAYLIS THERAPPrescription5 Jan 2016
ADAPALENE0.3%gel · topicalSUN PHARMA CANADAPrescription23 Jun 2016
ADAPALENE0.1%solution · topicalWAYLIS THERAPPrescription23 Sep 2016
ADAPALENE0.3%gel · topicalALEMBICPrescription18 Jun 2020
ADAPALENE0.1%gel · topicalSUN PHARMA CANADAOver-the-counter14 Jan 2022
ADAPALENE0.1%gel · topicalUNIQUEOver-the-counter30 Jun 2026
DIFFERIN0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**solution · topicalGALDERMA LABS LPDiscontinued31 May 1996
DIFFERIN0.1%lotion · topicalGALDERMA LABS LPDiscontinued17 Mar 2010

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
DIFFERIN021487490.1 %GEL · TOPICALGALDERMA CANADA INC.
DIFFERIN022315920.1 %CREAM · TOPICALGALDERMA CANADA INC.
DIFFERIN XP022740000.3 %GEL · TOPICALGALDERMA CANADA INC.

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACADAPALENE 0.1% CREAM$2.85454per GM23 Sep 2026
US NADACADAPALENE 0.1% GEL$0.4655per GM23 Sep 2026
US NADACADAPALENE 0.1% GEL$0.33648per GM23 Sep 2026
US NADACADAPALENE 0.3% GEL$0.50376per GM23 Sep 2026
US NADACADAPALENE 0.3% GEL PUMP$0.85025per GM23 Sep 2026
US NADACGNP ADAPALENE 0.1% GEL$0.4655per GM23 Sep 2026
NHS Drug TariffAdapalene 0.1% cream£18.2650 gram1 Oct 2026
NHS Drug TariffAdapalene 0.1% gel£18.2650 gram1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

  • US FDA 27 Dec 2023 DIFFERIN — safety-related labeling change
    Labeling sections changed: Contraindications; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
  • US FDA 19 Apr 2023 DIFFERIN — safety-related labeling change
    Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
  • US FDA 27 Apr 2022 EPIDUO FORTE — safety-related labeling change
    Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide

All safety entries for adapalene →

Combinations containing Adapalene

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.